Doctor Evan Melrose Selected Aspen Institute Leadership Fellow

Thursday, July 20, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

AUSTIN, Texas, July 20, 2017 /PRNewswire/ -- Evan S. Melrose MD, MBA, founder and managing

director of Spindletop Capital, has been named a Health Innovators Fellow by The Aspen Institute.  Modeled after the Henry Crown Fellowship, the Health Innovators Fellowship was created in 2015 to strengthen the leadership of innovators across the US
health care ecosystem and to connect, inspire, and challenge them to create new approaches that will improve the health and well-being of all Americans.  Fellows are also admitted into the Aspen Global Leadership Network (AGLN), a worldwide community of entrepreneurial leaders from business, government and the nonprofit sector—currently, more than 2,400 Fellows from over 50 countries—who share a commitment to enlightened leadership and to using their extraordinary creativity, energy and resources to tackle the foremost societal challenges of our times.

"Dr. Melrose has shown been a healthcare leader though out his entire career.  Over twenty years ago he was selected as the first AUL/One America Otis Bowen Scholar (named after the Indiana Governor and former Secretary of Health and Human Services) and also in the same year as the American Medical Association Health Policy Fellow focused on Medicare reform.  Those transformational experiences in Washington led Evan to a lifelong career as a successful healthcare investor, family physician, educator, and leader," noted former Anthem Blue Cross and Blue Shield medical director and Spindletop colleague Dr. Robert McDonald, MD, MBA.  "Over the last two decades, whether he was serving as a volunteer in the Astrodome after Hurricane Katrina, promoting physical therapy for kids through teaching them magic, or serving on many private and public healthcare company boards, his authentic servant leadership has served as a model for the dozens of medical and business students that he has mentored over the years."

Tom Kowalski, president of the Texas Healthcare and BioScience Institute notes "Evan has been a business and thought leader in Texas over the last 15 years.  He has been involved with or led most every healthcare initiative from the Texas Life Science Forums to the Texas cancer initiatives and Impact Pediatrics at SXSW each year.  His leadership was recognized by his Texas peers when he was selected for both the Texas Lyceum and the Texas Business Hall of Fame Foundation boards and executive committees.  We are proud to have now serve the Aspen Institute as a Fellow."

Evan Melrose is managing director of Spindletop Capital, a healthcare private equity firm he founded in 2011 to provide expansion capital and operating expertise to transformational healthcare companies and partner with exceptional entrepreneurs. With 25 years of experience across healthcare, Dr. Melrose possesses extensive investment, clinical, and operating experience in research, clinical practice, education, and health policy. Prior to Spindletop Capital, Evan was founding managing director of PTV Sciences, a Texas based venture capital firm, and a director with Burrill & Company, a San Francisco-based life science private equity/venture capital firm. At Burrill he managed investments on behalf of partners including IBM, Aventis, P&G, Nestle, and Bayer. His board and operating experience includes Bioventus, Sanova Dermatology, IntersectENT, BioForm Medical, Biomimetic Therapeutics, and Inhibitex. Evan has held faculty appointments at the University of California-San Francisco, the University of Pennsylvania, and Baylor College of Medicine. As a family physician, Evan continues to see patients and maintains licensure in several states. He has served on several non-profit boards and respective executive committees including the Texas Business Hall of Fame Foundation, the University of Texas Hillel Foundation, the Texas Lyceum, and is a member of Young Presidents Organization. In 1996 he worked on Medicare reform as an American Medical Association health policy fellow and is the recipient of the AMA/Glaxo Wellcome Leadership Award. Evan received his BA from the University of Pennsylvania, received an MD from Indiana University School of Medicine, and an MBA from The Wharton School. He is certified as a public company director by Institutional Shareholder Services/UCLA Anderson School of Business. In 2013 the National Association of Corporate Directors (NACD) elected Evan as a NACD Board Leadership Fellow, their highest level of credentialing for corporate directors. Evan is a Fellow of the third class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.

About Spindletop Capital Management

Spindletop Capital, founded in 2011, is a healthcare investment firm focused on providing expansion capital for commercial stage healthcare companies. Based in Austin, Spindletop is managed by an unrivaled team of investment professionals and advisors with deep operating, technical, and transactional experience. Spindletop Capital leverages the organization's deep experience, broad network and proprietary access to Texas resources to enhance value for management teams and financing syndicates. Spindletop Capital invests nationally across all sectors of healthcare including medical devices, diagnostics, healthcare services, healthcare IT, specialty pharmaceuticals and biotechnology.  For more information, visit

About The Aspen Institute

The Aspen Institute is an educational and policy studies organization based in Washington, DC. Its mission is to foster leadership based on enduring values and to provide a nonpartisan venue for dealing with critical issues. The Institute is based in Washington, DC; Aspen, Colorado; and on the Wye River on Maryland's Eastern Shore. It also has offices in New York City and an international network of partners. For more information, visit

Contact: Mitun Ranka 1-512-961-4633 admin(at)


View original content:

SOURCE Spindletop Capital

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store